Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research



High Sensitivity C-Reactive Protein: Could it be used as a Cardiovascular Risk Predictor in Hemodialysis Patients?

Sefer Usta, Hamit Serdar Basbug, Yavuz Cakiroglu.

Abstract
Objective: We aimed to investigate the correlation between the chronic renal failure (CRF) and cardiovascular risk in hemodialysis (HD) patients according to the serum high-sensitive C-reactive protein (hs-CRP).
Methods: A hundred patients were divided into two groups. In the first group, there were 50 patients (20 females, 30 males) who receive hemodialysis (HD) due to CRF. In the second group, which is arranged as a control group, there were 50 patients (22 female, 28 male) having a cardiovascular risk, but without CRF. CRP values were determined in both groups.
Results: The average duration of dialysis patients is 38.8536.66 months. Average hs-CRP values were determined as 19.086 mg/L (First year HD), 23.280 mg/L (Second year HD), 19.367 mg/L (Third year HD), 23.350 mg/L (Fourth year HD), 26.970 mg/L (Five and more years HD), 3.178 mg/L (non-CRF, non-revascularisation), 14.386 mg/L (non-CRF, revascularization)(Table 2). The hs-CRP values were increasing with years of HD, except the third year of HD. In the third year HD patients, hs-CRP levels revealed a slight decrease.
Conclusion: The high level of hs-CRP indicates who may be at risk for coronary incident. Elevated serum CRP levels are associated with other atherosclerotic vascular diseases in HD patients. In recent years, various studies have shown that the high levels of CRP in HD patients become a strong determinant of mortality and morbidity. High levels of hs-CRP in CRF patients should be evaluated as an indication of a rapid onset of a coronary artery disease.

Key words: Chronic renal failure; High sensitive; C-Reactive Protein; hs-CRP; cardiovascular disease



Share this Article


Advertisement
Oxidants and Antioxidants in Medical Science

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.